<?xml version="1.0" encoding="UTF-8"?><html xmlns="http://www.w3.org/1999/xhtml" xmlns:oboInOwl="http://www.geneontology.org/formats/oboInOwl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:obo="http://purl.obolibrary.org/obo/" xmlns:owl="http://www.w3.org/2002/07/owl#" xmlns:xsd="http://www.w3.org/2001/XMLSchema#" xmlns:rdfs="http://www.w3.org/2000/01/rdf-schema#" xmlns:dublincorens="http://purl.org/dc/elements/1.1/"  version="XHTML+RDFa 1.0" ><body>In Absence Sonic Hedgehog, p53 Induces <br /> Apoptosis Inhibits Retinal Cell Proliferation, Cell- <br /> Cycle Exit Differentiation Zebrafish <br /> Sergey V. Prykhozhij*&#194;&#164; <br /> Developmental Biology Unit, European Molecular Biology Laboratory, Heidelberg, Germany <br />  <br />  <br />  <br />     Abstract <br />     Background: Sonic hedgehog (Shh) signaling regulates cell proliferation vertebrate development induction     cell-cycle regulator gene expression activation signalling pathways, prevents cell death unclear <br />     mechanism required differentiation retinal cell types.  unsolved question signalling <br />     molecule regulate distinct cell processes proliferation, cell survival differentiation. <br />  <br />     Methodology/Principal Findings: Analysis zebrafish shh2/2 mutant revealed context p53 mediates <br />     elevated apoptosis nervous retina development interferes retinal proliferation     differentiation. shh2/2 mutants activation p53 target genes p53-mediated apoptosis, increase <br />     Hedgehog (Hh) signalling expression dominant-negative Protein Kinase strongly decreased p53 target gene <br />     expression apoptosis levels shh2/2 mutants. Using novel p53 reporter transgene, confirm p53 active     tissues require Shh cell survival. Proliferation assays revealed loss p53 rescue normal cell-cycle exit     mitotic indices shh2/2 mutant retina 24, 36 48 hpf.  generation amacrine cells     photoreceptors strongly enhanced double p532/2shh2/2 mutant retina suggesting effect p53 retinal <br />     differentiation. <br />  <br />     Conclusions: Loss Shh signalling leads p53-dependent apoptosis developing nervous retina. <br />      Shh-mediated control p53 activity required proliferation cell cycle exit retinal cells     differentiation amacrine cells photoreceptors. <br />  <br />   Citation: Prykhozhij SV (2010) Absence Sonic Hedgehog, p53 Induces Apoptosis Inhibits Retinal Cell Proliferation, Cell-Cycle Exit Differentiation <br />   Zebrafish. PLoS 5(10): e13549. doi:10.1371/journal.pone.0013549 <br />   Editor: Amit Singh, University Dayton, United States America <br />   Received June 28, 2010; Accepted September 30, 2010; Published October 21, 2010 <br />   Copyright: &#195;&#376; 2010 Sergey V. Prykhozhij. open-access article distributed terms Creative Commons Attribution License, permits <br />   unrestricted use, distribution, reproduction medium, provided original author source credited. <br />   Funding: study supported laboratory budget funds European Molecular Biology Laboratory (EMBL) Heidelberg labs Carl Neumann   Francesca Peri. author supported fellowship EMBL International PhD Program later post-doctoral fellowship EMBL Heidelberg, <br />   web address: http://www.embl  funders role study design, data collection analysis, decision publish, preparation manuscript. <br />   Competing Interests: author declared competing interests exist. <br />   * E-mail: rykhozh@embl   &#194;&#164; Current address: Max Planck Institute Molecular Genetics, Berlin, Germany <br />  <br />  <br />  <br /> Introduction                                                                            Interestingly, neural tube Shh signalling promotes cell <br />                                                                                         survival requirement tissue patterning differen- <br />    organogenesis, cell numbers tightly controlled                         tiation [13] arguing hypothesis Shh prevents cell <br /> balancing proliferation cell death. Hh signaling pathway                            death providing patterning cues. <br /> regulates cell proliferation survival development                             controversy  <br /> addition pattern formation differentiation functions                      lying mechanism anti-apoptotic role Shh. Activation different biological contexts (reviewed [1,2,3]). Work                     anti-apoptotic genes Shh signaling simplest scenario, labs shown secreted Hh proteins bind                                Gli1 activate BCL2 gene expression human cell <br /> transmembrane protein Patched (Ptc) release inhibition                       lines mouse keratinocytes binding near- transmembrane protein Smoothened (Smo) Ptc. signal                           consensus sites BCL2 promoter [14]. Likewise,  <br /> transduction downstream Smo inhibits proteolytic processing                       expression Gli3 dominant-active form developing chick <br /> Gli2 Gli3 repressive forms, mediated Protein                         embryos leads induction Bcl2 gene [13].  Kinase (PKA) factors [4]. resulting                          study proposed absence Shh, Patched1 mediates <br /> length Gli factors activate target genes.                                     apoptosis neural tube caspase activation indepen- <br />    Shh essential survival factor cell types                       dent canonical Shh signaling pathway [15]. Patched1 development neural stem cells [5], cells neural tube                     function context dependency receptor, e. receptor <br /> [6,7,8], midbrain forebrain [9], neural crest [10,11], retina                       inducing cell death absence cognate ligand binding <br /> [12], ventral sclerotome [7]. findings supported                       [16,17]. Recently, Abe colleagues (2008) shown fact restoring Shh signalling suppress apoptosis [6,8].                    activation Hh signaling suppress p53 pathway human cell <br />  <br />  <br />        PLoS | www.plosone.org                                                   1                             October 2010 | Volume 5 | Issue 10 | e13549 <br />                                                                                                                      p53 Activation shh Mutant <br />  <br />  <br /> lines [18]. authors proposed Hh signaling induces             cyclinG1, bax1, puma p21 24 hpf neural tube, retina unknown Mdm2- activating factor leading phosphorylation               somites shh2/2 mutant relative wild-type embryos serines 166 186 Hdm2 (human Mdm2),                  (Fig. 1A) elevated expression p53 56 hpf shh2/2 <br /> activated catalyses ubiquitination p53. Degradation               mutant retina, midbrain branchial arches (Fig. 1B). ubiquitinated p53 disrupts p53-mediated tumour suppression                  observed elevated p53 expression induction short conditions DNA damage oncogenic stress.                        D113 p53 transcript isoform [37,38] shh2/2 mutant, <br /> Furthermore, Stecca Ruiz Altaba (2009) described               level length p53 transcript comparable <br /> negative feedback loop p53 Gli1 transgenic mouse             shh2/2 mutant wild-type embryos (Fig. 1C). models [19]. authors p53 inhibits activity Gli1           better measure p53 target gene expression levels, performed interfering normal nuclear localization directing        quantitative polymerase chain reaction (qPCR) analyses shh2/2 proteosomal degradation. Closing loop, Gli1 overexpression           mutant versus wild-type embryos 24 hpf 56 hpf confirming <br /> leads striking increase Mdm2 expression                    elevated expression p53, p21 mdm2, cycG1, bax1 puma regulation p53 mouse brain cell lines.                shh2/2 mutants stages (Fig. 1D, E). pro-apoptotic <br />    anti-apoptotic function, Shh known                genes bax1 puma, noxa, showed higher expression stimulate proliferation direct regulation cell-cycle promoting        shh2/2 mutants compared wild-type embryos 24 hpf <br /> genes activation secondary signaling pathways.                (Fig. 1D) 56 hpf (Fig. 1E), relative expression puma,    particular, Hh ligands stimulate proliferation mouse           potent inducer mitochondrial apoptosis [39,40], skin [20], vertebrate central nervous [13,21,22,              higher shh2/2 mutant embryos 24 hpf (Fig. 1D) 56 <br /> 23,24,25], Drosophila wing [26,27] eye imaginal discs            hpf (Fig. 1E) correlating higher level apoptosis 24 hpf <br /> [28]. vertebrate retina, Shh stimulates proliferation             (Fig. 2). <br /> retinal progenitors vitro [29,30] ciliary marginal zone          confirm p53 essential elevated apoptosis [31].  mouse retina development Shh-mediated                shh2/2 mutant, used morpholino oligonucleotides (MO) [41] <br /> activation cyclinD1 expression essential proliferation        knock p53 previously shown effectively block p53 <br /> cell-cycle exit retinal ganglion cell progenitors [32]. Consistent       translation zebrafish development [42]. Injection p53  zebrafish shh2/2 mutant retina, proliferation          MO 4-mismatch control MO shh2/2 mutant <br /> reduced neurogenesis [12]. Xenopus, Shh signalling            embryos suppressed elevated apoptosis neural tube 24 hpf shown promote retinal progenitor proliferation                   (Fig. 2A) confirmed using image quantification apoptosis <br /> activating expression cell cycle regulators, shortens G1-          stainings (Fig. 2A&#226;&#8364;&#8482;) retina 56 hpf (Fig. 2C). Apoptosis G2-phases cell cycle, drives cells           occur extrinsic pathway cells receive final mitosis cell-cycle exit [33]. Interestingly,       external signals activating death receptors intrinsic (mitochon- contexts Hh signalling shown negatively regulate          drial) pathway pro-apoptotic factors released cell cycle progression [34].  zebrafish shh2/2 mutant             mitochondria permeabilization, p53 activating primar- <br /> retina Hh signaling inhibition forskolin, retinal         ily intrinsic extrinsic apoptotic pathway [43]. <br /> cells fail express p57Kip2 cyclin-dependent kinase (CDK)                 test p53 activates mitochondrial pathway inhibitor exit cell cycle [35,36].                           apoptosis shh2/2 mutant, injected mRNA EGFP-bcl2, <br />    study shows loss shh zebrafish leads p53-             inhibitor mitochondrial apoptotic pathway, EGFP <br /> mediated apoptosis developing nervous retina.             shh2/2 mutant wild-type embryos. Expression EGFP- <br /> Consistent  activation Hh signalling suppresses p53            bcl2 significantly reduced level apoptosis shh2/2 mutants <br /> activity apoptosis shh2/2 mutant. monitor p53                 24 hpf, EGFP did effect (Fig. 2B, B&#226;&#8364;&#8482;) <br /> activation, created p53 reporter transgenic line expressing             suggesting p53-mediated apoptosis shh2/2 mutant <br /> nuclear green fluorescent protein control p53-sensitive            occurs intrinsic pathway. <br /> promoter, verified p53 knock induced roscovitine treatment. using line, determined            p53-dependent apoptosis shh2/2 mutant retina <br /> spatio-temporal activation p53 apoptosis shh2/2                  determine genetic loss p53 rescue excessive <br /> mutant.  comparisons double p532/2shh2/2 mutants                 apoptosis shh2/2 mutant, p532/2shh2/2 double mutant wild-type, shh2/2 mutant embryos identified p53-                   animals generated using previously published tp53M214K <br /> mediated inhibition retinal progenitor proliferation, cell-cycle         mutant zebrafish [44].  high level apoptosis shh2/2 <br /> exit differentiation amacrine cells photoreceptors.              mutants 24 hpf (Fig. 3A-b) retina 72 hpf (Fig. 3B- <br /> Taken  data provide novel genetic evidence              b) compared wild-type (Fig. 3A  3B  reduced Shh regulates cell survival nervous retina                p532/2shh2/2 mutant (Fig. 3A-c) wild-type level (Fig. 3A-c, <br /> development retinal proliferation differentiation            3B-c). examined differentiation status apoptotic cells inhibition p53 pathway.                                          wild-type shh2/2 mutant retinas 72 hpf staining cells <br />                                                                             neuronal marker HuC apoptotic cells using TdT-mediated <br /> Results                                                                     <span id='am-14' about='obo:IMR_0200056' typeof='owl:Thing obo:IMR_0000947 obo:IMR_0000001 obo:IMR_0001998'><span id='am-15' property="rdfs:label" content="dUTP" datatype="xsd:string"></span><span id='am-16' property="oboInOwl:id" content="IMR:0200056" datatype="xsd:string"></span><span id='am-17' property="oboInOwl:hasOBONamespace" content="molecule_role" datatype="xsd:string"></span><span id='am-18' property="oboInOwl:hasDbXref" content="KEGG:C00460" datatype="xsd:string"></span>dUTP</span>-biotin nick end labelling (TUNEL). wild-type retina, <br />                                                                             HU-positive negative apoptotic present (Fig. 3C . <br /> p53 mediates apoptosis shh2/2 mutant                             contrast, apoptotic cells shh2/2 mutant retina intrinsic apoptotic pathway                                                 undifferentiated (HuC-negative) (Fig. 3C-b), HU- <br />    determine mechanism cell death loss shh,           positive (Fig. 3C-b) suggesting differentiating cells die analysed expression anti-apoptotic Bcl-2 family genes bcl2,          apoptosis shh2/2 mutant retina. <br /> bcl2l, mcl1a mcl1b shh2/2 mutant wild-type embryos, expression comparable embryos genotypes              PG13p21::nlsEGFP, p53 reporter living zebrafish 24 hours post fertilization (hpf) (Fig. S1). looked        embryos <br /> expression p53-dependent genes situ hybridisations             study behaviour characteristics cells revealed consistently stronger expression p53 target genes p53,          undergone activation p53, constructed transgenic reporter  <br />  <br />       PLoS | www.plosone.org                                        2                         October 2010 | Volume 5 | Issue 10 | e13549 <br />                                                                                                                          p53 Activation shh Mutant <br />  <br />  <br />  <br />  <br /> Figure 1. Induction p53 target gene expression shh2/2 mutant.   24 hpf wild-type shh2/2 mutant embryos situ <br /> hybridised probes p53, cyclinG1, bax1, puma p21 mRNAs. p53 target genes expressed higher level shh2/2 <br /> mutant neural tube, retina somites wild-type embryos. (B) 56 hpf wild-type shh2/2 mutant embryos hybridized probe p53 mRNA. hybridizations increased expression p53 shh2/2 mutant compared wild-type embryos brain, retina branchial arches. following structures labelled: retina, midbrain (mb) branchial arches (ba). (C) p53 transcript isoforms shh2/2 <br /> mutant wild-type 24 56 hpf analysed semi-quantitative PCR assays length p53, D113 p53 transcripts b-actin transcript loading control. stages, length p53 b-actin transcripts expressed similar levels wild-type mutant samples, D113 p53 strongly upregulated shh2/2 mutant samples. (D, E) qPCR assays p53, p21, mdm2, cyclinG1, bax1, puma, noxa gapdh performed 24 hpf (D) 56 hpf (E) wild-type shh2/2 mutant embryos. cDNA embryos used 24 hpf samples cDNA embryo heads used 56 hpf samples. Gene expression normalized using gapdh expression reference. panels p53 target <br /> gene expression wild-type shh2/2 mutant embryos (D, E). Error bars represent standard deviation asterisk indicates statistical <br /> significance. significant expression differences wild-type shh2/2 mutant samples (t-test, * - p,0.05) genes noxa. <br /> qPCR assays performed triplicates different clutches embryos standard deviations shown. <br /> doi:10.1371/journal.pone.0013549.g001 <br />  <br />  <br />        PLoS | www.plosone.org                                         3                          October 2010 | Volume 5 | Issue 10 | e13549 <br />                                                                                                                             p53 Activation shh Mutant <br />  <br />  <br />  <br />  <br /> Figure 2. Knock p53 suppresses apoptosis shh2/2 mutant mediated intrinsic apoptosis pathway.   Apoptosis <br /> labelling using ApopTag staining wild-type shh2/2 mutant embryos 24 hpf injection p53 morpholino control morpholino. mount images head (head) neural tube (nt) shown.  ) Quantification ApopTag signal area wild-type shh2/2 mutant <br /> embryo head images   shows p53MO successfully decreased apoptosis shh2/2 mutant wild-type level. Asterisks (***) shh2/2 mutant bar indicate significant statistical differences samples (t-test, P-value,0,001). (B) Apoptosis labelling using ApopTag <br /> staining wild-type shh2/2 mutant embryos 24 hpf injection EGFP-bcl2 EGFP mRNA. mount images head <br /> (head) neural tube (nt) shown. (B&#226;&#8364;&#8482;) Quantification ApopTag signal area wild-type shh2/2 mutant embryo head images (B) <br /> shows EGFP-bcl2 successfully decreased apoptosis shh2/2 mutant wild-type level. Asterisks (***) shh2/2 mutant bar <br /> indicate significant statistical differences samples (t-test, P-value,0,001). (C) Retinal apoptosis observed shh2/2 mutant 56 hpf suppressed injection p53 morpholino injection control morpholino (n = 10 40 sections shh2/2 mutant injected p53 <br /> morpholino; n = 10 34 sections shh2/2 mutant injected control morpholino). *** - t-test, P-value,0,001. <br /> doi:10.1371/journal.pone.0013549.g002 <br />  <br /> monitor p53 activity using strategy similar used                combined p53-sensitive promoter. Tol2kit transgenic <br /> construct p53 reporter human cell lines [45]. 2,4 kb                     [47] used assemble final construct <br /> promoter fragment human CDKN1A encoding p21 CDK                              containing PG13p21 promoter, nlsEGFP coding sequence inhibitor 13 copies optimal p53 binding site (PG13) [46]             polyA signal (Fig. 4A). <br />  <br />  <br />        PLoS | www.plosone.org                                           4                          October 2010 | Volume 5 | Issue 10 | e13549 <br />                                                                                                                             p53 Activation shh Mutant <br />  <br />  <br />  <br />  <br /> Figure 3. Genetic loss p53 suppresses apoptosis shh2/2 mutant. Apoptosis assayed mount embryos using ApopTag   c) retinal sections using TUNEL labelling (B, c). sections oriented anterior  Elevated apoptosis shh2/2 <br /> mutant embryos compared wild-type embryos suppressed p53 loss developing nervous   c) retina (B, c).   mount ApopTag staining 24 hpf wild-type, shh2/2 p532/2shh2/2 embryos  c). (B) TUNEL/DAPI staining retinal sections wild-type, <br /> shh2/2 p532/2shh2/2 embryos 72 hpf  c). (C) Wild-type   shh2/2 mutant (b) retinal cryosections 72 hpf embryos stained anti-HU <br /> antibodies detect retinal neurons TUNEL <span id='am-19' about='rdfs:label' typeof='owl:Thing'>label</span> apoptotic cells. Cells positive HU TUNEL indicated arrows cells positive TUNEL labelled arrowheads. Images obtained retinal sections 10 embryos representative overlay images shown. <br /> doi:10.1371/journal.pone.0013549.g003 <br />  <br />    p53 reporter zebrafish transgenic line general tool study        mutants expressed higher level nlsEGFP contained <br /> p53 activation regulation. Studies p53 zebrafish employed             TUNEL-positive cells midbrain, hindbrain camptothecin, genotoxic drug, roscovitine, CDK inhibitor,             spinal cord wild-type embryos (Fig. 5B, C, D). detected <br /> induce p53-dependent apoptosis [42,48]. verify p53 reporter             56 hpf shh2/2 mutant hindbrain expressed p53 reporter <br /> line used bona fide p53 reporter vivo, treated p53        higher level wild-type embryos (Fig. 5F). contrast, <br /> reporter transgenic fish roscovitin. Wild-type embryos carrying            shh2/2 mutant retina showed strong expression p53 reporter p53 reporter transgene incubated 50 mM                     elevated apoptosis 24 hpf (Fig. 5A). result roscovitine 0.4% DMSO control 6 hours starting 24 hpf.           interesting unexpected shh expression starts retina 28 <br /> p53 reporter expression strongly regulated brain              hpf [49].  56 hpf shh2/2 mutant retina, p53 <br /> retina roscovitine-treated control DMSO-treated                   reporter expression number TUNEL-positive cells high <br /> embryos (Fig. 4B). Furthermore, knocking p53 morpho-                  compared wild-type (Fig. 5E). Activation p53 shh2/2 mutant <br /> lino shh2/2 mutant strongly inhibited expression p53 reporter             retinal cells 28 hpf indicates require Shh signalling <br /> transgene 24 hpf (Fig. 4C).  shh2/2 mutant retina            earlier stage control p53 activity. absence Shh, 56 hpf, apoptotic cells showed localisation active                neural crest cells undergo apoptosis [10] p53 <br /> Caspase3 labeling p53 reporter nlsEGFP cytoplasm                    reporter positive cells present midbrain located region <br /> (Fig. 4D) suggesting apoptosis induced cells active p53.        populated neural crest cells (Fig. 5B). p53 reporter labeled localised pixels 20,9 +/2 3,8% total active Caspase 3                somite cells (Fig. 5D), likely sclerotome cells requiring Shh <br /> pixels, 11,7 +/2 4,5% total p53 reporter nlsEGFP pixels,            survival [7]. difference significant (t-test, P-value,0,001), (Fig. 4E) <br /> suggesting apoptotic cells expressing p53 reporter frequent p53 reporter-positive cells undergoing apoptosis,                 Hh signalling activation dnPKA-GFP decreases <br /> consistent p53 activating caspases downstream result           cyclinG1 expression apoptosis shh2/2 mutant <br /> activity.                                                                       embryos 12-somite stage <br />                                                                                   tissue culture experiments, p53 activation shown Expression p53 reporter tissues requiring Shh                         inhibited Gli-mediated activation unknown p53 <br /> survival                                                                        pathway inhibitor [18]. leads question   analysed p53 reporter expression 24 hpf 56 hpf               activation Hh signalling inhibits p53 pathway vivo shh2/2 mutant wild-type embryos (Fig. 5). 24 hpf, shh2/2             absence Shh. activate canonical Hh/Gli signaling <br />  <br />  <br />        PLoS | www.plosone.org                                           5                          October 2010 | Volume 5 | Issue 10 | e13549 <br />                                                                                                                          p53 Activation shh Mutant <br />  <br />  <br />  <br />  <br /> Figure 4. Zebrafish p53 reporter line construction verification.   p53 reporter PG13p21::nlsEGFP-polyA constructed using Tol2kit described Materials methods. consists p21 promoter fused p53-binding enhancer sequence PG13, nlsEGFP coding sequence polyadenylation signal (polyA). (B) Wild-type embryos carrying p53 reporter transgene incubated 6 hours 24 hpf 50 mM Roscovitine 0.4% DMSO diluted E3 medium. DMSO-treated embryos did significant expression reporter (right), roscovitine-treated ones expressed p53 reporter high level (left). embryos showed green-heart transgenesis marker. experiment repeated times 20 embryos used treatment. (C) p53 morpholino 4-mismatch control morpholino injection <br /> suppressed expression PG13p21::nlsEGFP p53 reporter shh2/2 mutant embryos 24 hpf. injections effect p53 reporter <br /> expression wild-type embryos. (D) Anti-active Caspase3 staining cells shh2/2 mutant retina 56 hpf expressing p53 reporter <br /> transgene PG13p21::nlsEGFP. cells positive active Caspase3 expressed p53 reporter transgene. Single channel, overlay  <br /> localisation analysis images shown. (E) Quantification localisation active Caspase3 staining nlsEGFP p53 reporter signal. localised <br /> pixels 20,9 +/2 3,8% total active Caspase3 pixels 11,7 +/2 4,5% total nlsEGFP pixels. Quantifications performed 20 retinal <br /> section images 10 embryos. Asterisks (***) indicate significant statistical difference proportions (t-test, P-value,0,001). <br /> doi:10.1371/journal.pone.0013549.g004 <br />  <br />  <br /> pathway, injected mRNA dominant-negative PKA fused                  embryos stronger cyclinG1 expression. EGFP <br /> GFP (dnPKA-GFP) [50,51] EGFP mRNA control                        mRNA injection proportion embryos &#226;&#8364;&#732;&#226;&#8364;&#732;high&#226;&#8364;&#8482;&#226;&#8364;&#8482; <br /> progeny fish heterozygous shh deletion. Given limited          expression cyclinG1 25,3 +/2 1,2% (Fig. 6D), 6 +/2 <br /> mRNA stability, analysed effects RNA injections 12            2% (Fig. 6D) dnPKA-GFP -injected embryos perceptibly <br /> somites stage, shh2/2 mutant embryos higher               stronger cyclinG1 expression embryos samples <br /> level p53 target gene expression apoptosis wild-type              (Fig. 6D). Overexpression dnPKA-GFP reduced embryos (Fig. S2). EGFP-injected embryos showed                 proportion embryos higher apoptosis levels (Fig. 6C) unaltered wild-type shh2/2 mutant patched1 expression pattern              5,8 +/2 2,4% (Fig. 6D) (Fig. 6D) compared 24,7 +/2 1,53% <br /> (Fig. 6A, D, &#226;&#8364;&#732;&#226;&#8364;&#732;low&#226;&#8364;&#8482;&#226;&#8364;&#8482;), expression dnPKA-GFP led ectopic            (Fig. 6D) EGFP-injected embryos (Fig. 6D). Taken <br /> spreading patched1 expression 87,7 +/2 3,8% embryos                   data indicate activation Hh signalling using <br /> (Fig. 6A, D, &#226;&#8364;&#732;&#226;&#8364;&#732;high&#226;&#8364;&#8482;&#226;&#8364;&#8482;). assessed expression cyclinG1, p53           dnPKA-GFP suppress p53 target expression apoptosis. <br /> target gene, mRNA injections visually scoring expression <br /> strength &#226;&#8364;&#732;&#226;&#8364;&#732;high&#226;&#8364;&#8482;&#226;&#8364;&#8482; &#226;&#8364;&#732;&#226;&#8364;&#732;low&#226;&#8364;&#8482;&#226;&#8364;&#8482; based staining uninjected               p53 regulates mitotic indices shh2/2 mutant <br /> embryos (Fig. 6B), embryos &#226;&#8364;&#732;&#226;&#8364;&#732;high&#226;&#8364;&#8482;&#226;&#8364;&#8482; cyclinG1 expression            retina inferred shh2/2 mutant &#226;&#8364;&#732;&#226;&#8364;&#732;low&#226;&#8364;&#8482;&#226;&#8364;&#8482;                         determine effect p53 loss proliferation expression wild-type (control stainings wild-type embryos,            absence Shh, quantified mitotic cells wild-type, p532/2, shown). experiment, effect dnPKA-GFP p53                shh2/2 p532/2shh2/2 mutant retinas 24, 34 48 hpf <br /> target gene expression inferred change proportion           stages staining retinal sections Ser10-phosphorylated form <br />  <br />  <br />        PLoS | www.plosone.org                                         6                          October 2010 | Volume 5 | Issue 10 | e13549 <br />                                                                                                                       p53 Activation shh Mutant <br />  <br />  <br />  <br />  <br /> Figure 5. Expression p53 reporter apoptosis strongly elevated shh2/2 mutant embryos. Wild-type shh2/2 embryos 24hpf  D) 56 hpf (E, F) carrying p53 reporter transgene (PG13p21::nlsEGFP) transversally sectioned, nuclei stained DAPI apoptotic cells &#226;&#8364;&#8220; TUNEL, nlsEGFP signal endogeneous  F). developing nervous shh2/2 mutant embryos showed high level p53 reporter expression apoptosis compared wild-type embryos 24 (B&#226;&#8364;&#8220;D) 56 hpf (F).   24 hpf, p53 reporter strongly <br /> induced shh2/2 mutant compared wild-type retina, elevated apoptosis shh2/2 mutant retina. (B) Expression p53 reporter TUNEL labeling midbrain shh2/2 mutant wild-type embryos 24 hpf. (C) Expression p53 reporter TUNEL labeling hindbrain shh2/2 mutant wild-type embryos 24 hpf. (D) Expression p53 reporter TUNEL labelling spinal cord shh2/2 wild- <br /> type 24 hpf. (E) 56 hpf, p53 reporter expression apoptosis higher shh2/2 retina wild-type retina. (F) <br /> Expression p53 reporter TUNEL labelling hindbrain regions shh2/2 wild-type embryos 56 hpf. <br /> doi:10.1371/journal.pone.0013549.g005 <br />  Histone3 (pH 3), reliable marker late G2-phase             mutant retina 24 hpf neurogenesis shed light mitosis [52]. 24 hpf, retinal cells zebrafish highly              role p53 early progenitor proliferation cell cycle <br /> proliferative exiting cell cycle, 34 48        exit. Retinal mitotic indices 24 hpf wild-type (14,9 +/2 2,4%) <br /> hpf, retinal cells exiting cell cycle acquire terminal          (Mean +/2 standard deviation), p532/2 (15,3 +/2 2,4%) fates. Analysis p53 affects proliferation shh2/2              p532/2shh2/2 (13,1 +/2 1,9%) pairwise significantly <br />  <br />  <br />        PLoS | www.plosone.org                                       7                         October 2010 | Volume 5 | Issue 10 | e13549 <br />                                                                                                                                p53 Activation shh Mutant <br />  <br />  <br />  <br />  <br /> Figure 6. Hh signaling activation dnPKA-GFP decreases p53 target cyclinG1 expression suppresses apoptosis shh2/2 mutant <br /> embryos. Embryos shh+/&#226;&#8364;&#8220; parent fish injected dnPKA-GFP EGFP mRNA, grown 12-somite stage situ stained patched1, target gene Hh signaling, cyclinG1, p53 target gene, ApopTag staining performed characterize level apoptosis.   <br /> Injection dnPKA-GFP led strongly increased widely spread expression patched1 (category &#226;&#8364;&#732;&#226;&#8364;&#732;high&#226;&#8364;&#8482;&#226;&#8364;&#8482;) 87,7+/23,8% injected <br /> embryos, rest having normal wild-type low shh2/2 mutant patched1 expression comparable expression patched1 EGFP-injected embryos shh+/&#226;&#8364;&#8220; parent fish (category &#226;&#8364;&#732;&#226;&#8364;&#732;low&#226;&#8364;&#8482;&#226;&#8364;&#8482;). (B) Expression cyclinG1 uninjected embryos shh+/&#226;&#8364;&#8220; parent fish. Categories &#226;&#8364;&#732;&#226;&#8364;&#732;high&#226;&#8364;&#8482;&#226;&#8364;&#8482; &#226;&#8364;&#732;&#226;&#8364;&#732;low&#226;&#8364;&#8482;&#226;&#8364;&#8482; indicate <br /> expression levels shh2/2 mutant wild-type embryos, respectively. (C) ApopTag staining apoptotic cells uninjected embryos shh+/&#226;&#8364;&#8220; <br /> parent fish. Categories &#226;&#8364;&#732;&#226;&#8364;&#732;high&#226;&#8364;&#8482;&#226;&#8364;&#8482; &#226;&#8364;&#732;&#226;&#8364;&#732;low&#226;&#8364;&#8482;&#226;&#8364;&#8482; indicate levels apoptosis shh2/2 mutant wild-type embryos, respectively. (D) Statistical analysis results injections dnPKA-GFP EGFP mRNA embryos shh+/&#226;&#8364;&#8220; parent fish. EGFP-injected embryos &#226;&#8364;&#732;&#226;&#8364;&#732;low&#226;&#8364;&#8482;&#226;&#8364;&#8482; expression patched1, 25,3 +/2 1,15% (Mean +/2 standard deviation) &#226;&#8364;&#732;&#226;&#8364;&#732;high&#226;&#8364;&#8482;&#226;&#8364;&#8482; expression cyclinG1 24,7 +/2 1,53% &#226;&#8364;&#732;&#226;&#8364;&#732;high&#226;&#8364;&#8482;&#226;&#8364;&#8482; apoptosis levels. <br /> dnPKA-GFP mRNA injection led &#226;&#8364;&#732;&#226;&#8364;&#732;high&#226;&#8364;&#8482;&#226;&#8364;&#8482; expression patched1 87,7 +/2 3,8% embryos decreased expression cyclinG1 apoptosis levels: <br /> &#226;&#8364;&#732;&#226;&#8364;&#732;high&#226;&#8364;&#8482;&#226;&#8364;&#8482; proportions 6 +/2 2% 5,8 +/2 2,4%, respectively. experiment 3 times 60 embryos used staining. <br /> Asterisks (***) shh2/2 mutant bars indicate significant statistical differences proportions (Fisher&#226;&#8364;&#8482;s exact test, P-value,0,001). <br /> doi:10.1371/journal.pone.0013549.g006 <br />  <br />        PLoS | www.plosone.org                                             8                           October 2010 | Volume 5 | Issue 10 | e13549 <br />                                                                                                                           p53 Activation shh Mutant <br />  <br />  <br /> different (P-value.0.1), differed significantly mitotic           p53 loss rescues amacrine photoreceptor cells index shh2/2 mutant (7,5 +/2 2,3%) (Fig. 7A, D), suggesting                 shh2/2 mutant retina p53 loss rescues early retinal progenitor proliferation                 address question p53 affects differentiation nearly normal level. 34 48 hpf, fewer                 shh2/2 mutant, retinal sections wild-type, shh2/2 p532/2 <br /> mitotic cells shh2/2 mutant wild-type retina                shh2/2 mutant embryos stained markers retinal cell <br /> (Fig. 7B, C). Strikingly, p532/2shh2/2 mutant retina contained             types. Staining HuC neuronal marker strongly labelled mitotic cells larger shh2/2 mutant retina             ganglion amacrine cells wild-type (Fig. 9A , 34 48 hpf (Fig. 7B, C). 34 hpf, mitotic indices             ganglion cells shh2/2 mutant retina (Fig. 9A-b), wild-type retina (11,8 +/2 1,73%) p532/2 mutant                     p532/2shh2/2 mutant retina, ganglion amacrine cells <br /> retina (12 +/2 1,46%) statistically different (t-test,                labelled (Fig. 9A-c). Consistently, retinal ganglion cells (RGCs) <br /> P = 0,67) suggesting p53 loss does increase                 identified anti-zn5 staining present retinas mitotic index (Fig. 7E). contrast, mitotic index shh2/2          genotypes (Fig. 9A-d, e, f).  amacrine cells labelled anti- <br /> mutant retina (7 +/2 1,38%) significantly lower                parvalbumin antibodies wild-type retina (Fig. 9A-g), wild-type retina p532/2shh2/2 retina (12,1 +/2 1,9%) (t-             absent shh2/2 retina (Fig. 9A-h) partially rescued test, P,0,001) (Fig. 7E), different wild-type mitotic             p532/2shh2/2 embryos (Fig. 9A  C). ratio area covered index (t-test, P = 0,55) (Fig. 7E). 48 hpf, mitotic indices          parvalbumine signal total retinal section area wild-type wild-type (11,1 +/2 2%) shh2/2 mutant (7,16 +/2                        retina (5,19 +/2 1,6%) significantly different ratio 1,25%) retinas significantly different (t-test, P,0,001)                  p532/2shh2/2 retina (2,03 +/2 0,32%), efficiency rescue <br /> (Fig. 7F), difference mitotic indices              39% (Fig. 9C). Investigating p53 affects differenti- p532/2shh2/2 mutant retina (11,6 +/2 1,54%) wild-                  ation photoreceptors, red-green cone rod <br /> type retina (t-test, P = 0,34) (Fig. 7F).  results 24, 34          photoreceptors present wild-type retina (Fig. 9A-j, m) 48 hpf conclusively demonstrate p53 decreases mitotic                 absent shh2/2 retina (Fig. 9A-k, n) rescued indices shh2/2 mutant retina early retinal progenitor            p532/2shh2/2 mutant retina (Fig. 9A-l, o), rescue proliferation neurogenesis.                                                complete relative areas photoreceptor labeling                                                                                different retinas wild-type p532/2shh2/2 <br /> p53 inhibits cell-cycle exit shh2/2 mutant retina                       embryos (Fig. 9C). Mu&#194;&#168;ller glia, cell type required maintain    normal mitotic index neurogenesis p532/2                  retinal environment, present wild-type retina 72 hpf <br /> shh2/2 retina result rescue cell-cycle exit               (Fig. 9A-p) nearly absent shh2/2 (Fig. 9A-q) p532/2 <br /> retinal progenitors p53 loss. hand, failure cell-           shh2/2 mutant retinas (Fig. 9A-r). Bipolar cells, retinal cell type <br /> cycle exit activate p53, p53 activation occurs               involved signal transduction light perception, earlier cell-cycle exit shh2/2 mutant retina                  labelled staining PKCa wild-type retina 72 hpf <br /> (Figs. 5, S2). distinguish scenarios, directly              (Fig. 9A-s), absent shh2/2 p532/2shh2/2 <br /> analyzed cell-cycle exit progression using hour 5-bromo-                   mutant retinas (Fig. 9A-t, u).  5 days post fertilization <br /> deoxyuridine (BrdU) incorporation wild-type, shh2/2                 (dpf), Mu&#194;&#168;ller glia bipolar cells appeared shh2/2 (Fig. 9B- <br /> p532/2shh2/2 mutant retinas 48 56 hpf stages, cell-                b, e) p532/2shh2/2 (Fig. 9B-c, f) mutant retinas similar levels <br /> cycle exit retina completed, subsequent                   indicating differentiation strongly delayed absence <br /> quantification BrdU-positive cells using 49,6-Diamidino-2-                  Shh affected p53 loss. control, checked phenylindol (DAPI) staining. 49 hpf, proportion BrdU-                loss p53 affects retinal differentiation positive cells shh2/2 retina (53,8 +/2 7%) significantly            differentiation retinal cell types wild-type p532/2 mutant <br /> higher (t-test, P-value,0,001) wild-type                    embryos comparable (Fig. S3). results suggest p53 <br /> (34,1 +/2 4,4%) p532/2shh2/2 retinas (39 +/2 2,8%),                     inhibits differentiation amacrine cells photoreceptors difference wild-type p532/2shh2/2 BrdU-positive                    shh2/2 mutant, affecting differentiation cell types. <br /> proportions significant (t-test, P-value,0,01) (Figs. 8A, <br /> D), suggesting slight delay cell-cycle exit p532/2shh2/2           Discussion <br /> retina compared wild-type. 57 hpf, cell-cycle exit retina progressed decreasing proportions BrdU-positive cells            p53 essential elevated apoptosis absence wild-type (17,1 +/2 1,3%) p532/2shh2/2 (19 +/2 2,8%)                    Shh <br /> embryos, significantly lower shh2/2                   vertebrates, Shh signalling crucial prevent cell death retina (55,8 +/2 5%) (t-test, P-value,0,001). Interestingly, 57             different contexts, mechanism Shh-mediated <br /> hpf BrdU proportions BrdU-positive cells wild-type               survival regulation unclear. clarify mechanism, p532/2shh2/2 retinas different (t-test, P-value.0,05),                focused apoptosis neural tube retina shh2/2 <br /> suggesting complete rescue cell-cycle exit shh2/2 retina           mutant. p53 loss.                                                                      examined Bcl2 family gene expression potential cause <br />    addressed hypothesis p53 loss shh2/2                 apoptosis shh2/2 mutant haven&#226;&#8364;&#8482;t detected retina induces expression p57kip2, cyclin-dependent kinase                differences wild-type shh2/2 mutant embryos (Fig. <br /> inhibitor essential cell-cycle exit zebrafish retina.        S1).  activation Hh signalling shown 38 hpf, p57kip2 expressed large areas wild-type               induce expression bcl2 gene mouse keratinocytes [14], chick <br /> p532/2shh2/2 mutant retinas, absent shh2/2 mutant                 spinal cord [13] maintain Bcl2 gene expression mouse <br /> retina (Fig. 8C), p53 strongly expressed              lymphoma cells [53].  Hh signalling activates Bcl2 expression shh2/2 mutant retina wild-type p532/2shh2/2                certain contexts, results suggest Shh signaling mutant retinas (Fig. 8C). Altogether, results suggest           required global regulation Bcl2 family genes delay cell-cycle exit shh2/2 mutant retina dependent           zebrafish development. p53 activity inhibiting expression CDK inhibitor                       p53 activates expression target genes p57kip2.                                                                       induces apoptosis neural tube retina absence  <br />  <br />        PLoS | www.plosone.org                                          9                          October 2010 | Volume 5 | Issue 10 | e13549 <br />                                                                                                                             p53 Activation shh Mutant <br />  <br />  <br />  <br />  <br /> Figure 7. p53 regulates mitotic index shh2/2 mutant retina early progenitor proliferation neurogenesis. pH 3/ <br /> DAPI staining wild-type, shh2/2 p532/2shh2/2 retinas 24 hpf  , 34 hpf (B) 48 hpf (C). stages, mitotic index shh2/2 retina lower wild-type retina, p532/2shh2/2 retina, mitotic index comparable wild-type <br /> retina. (D) Statistical analysis mitotic indices wild-type, p532/2, shh2/2 p532/2shh2/2 retinas 24 hpf, indices comparable wild- <br /> type (14,9%, SD = 2,4%), p532/2 (15,3%, SD = 2,4%), p532/2shh2/2 (13,1%, SD = 1,9%) embryos significantly higher shh2/2 mutant <br /> retina (7,5%, SD = 2,3%). (E) Statistical analysis mitotic indices wild-type, p532/2, shh2/2 p532/2shh2/2 retinas 34 hpf, comparable wild-type (11,8%, SD = 1,73%), p532/2 (12,02%, SD = 1,46%), p532/2shh2/2 (12,1%, SD = 1,9%) retinas, mitotic index shh2/2 <br /> mutant retina twice lower (7%, SD = 1,38%). (F) Statistical analysis mitotic indices wild-type, shh2/2 p532/2shh2/2 retinas 48 <br /> hpf, indices comparable wild-type (11,1%, SD = 2%) p532/2shh2/2 (11,6%, SD = 1,54%) embryos significantly higher shh2/2 mutant retina (7,16%, SD = 1,25%). 8 (D) 10 (E, F) embryos (2 retinal sections embryo) analysed genotype mean <br /> +/2 standard deviation indicated bars mitotic index statistics. Asterisks (***) shh2/2 mutant bars indicate significant <br /> statistical differences samples (t-test, P-value,0,001). <br /> doi:10.1371/journal.pone.0013549.g007 <br />  <br />        PLoS | www.plosone.org                                          10                          October 2010 | Volume 5 | Issue 10 | e13549 <br />                                                                                                                            p53 Activation shh Mutant <br />  <br />  <br />  <br />  <br /> Figure 8. Loss p53 rescues cell-cycle exit defect shh2/2 mutant retina. S-phase progression wild-type, shh2/2 p532/2shh2/2 <br /> mutants analysed 49 57 hpg hour labelling BrdU. Confocal sections stained anti-BrdU antibodies DAPI shown anterior    Anti-BrdU/DAPI staining wild-type, shh2/2 p532/2shh2/2 mutant retinas 49 hpf identified greater <br /> extent cell-cycle exit (fewer cells labelled) wild-type p532/2shh2/2 mutant shh2/2 retina. data stainings used quantification (D). (B) 57 hpf wild-type retina, BrdU-positive cells ciliary marginal zone (CMZ).  shh2/2 mutant retina, cells failed exit cell cycle. Like wild-type retina, cells p532/2shh2/2 mutant exited cell cycle proliferative cells located CMZ. (C) 38 hpf, p57kip2 expression high level wild-type p532/2shh2/2 mutant retinas, p57kip2 present shh2/2 mutant retina. contrast, p53 expression high shh2/2 <br /> mutant retina low wild-type p532/2shh2/2 mutant retinas. (D) Proportions BrdU-positive cells (S-phase indices) wild-type, <br /> shh2/2 p532/2shh2/2 retinas 49 hpf obtained confocal sections presented  . S-phase indices wild-type (34,1%, <br /> SD = 4,4%) p532/2shh2/2 (39%, SD = 2,8%) significantly lower shh2/2 mutant retina (53,8%, SD = 7%) (t-test, P- <br /> value,0,001), difference significant (t-test, P-value,0,01). (E) S-phase indices wild-type, shh2/2 p532/2shh2/2 <br /> retinas 57 hpf obtained confocal sections presented (B). S-phase indices wild-type (17,1%, SD = 1,3%) p532/2 <br /> shh2/2 (19%, SD = 2,8%) significantly different (t-test, P-value.0,05), significantly lower shh2/2 mutant retina <br /> (55,8%, SD = 5%) (t-test, P-value,0,001). Total 10 sections 5 embryos (2 retinal sections embryo) analysed genotype mean <br /> +/2 standard deviation indicated graph bars. Statistical differences evaluated using t-test P-values,0,01 (**) 0,001 (***). <br /> doi:10.1371/journal.pone.0013549.g008 <br />  <br />  <br />  <br />  <br />        PLoS | www.plosone.org                                          11                         October 2010 | Volume 5 | Issue 10 | e13549 <br />                                                    p53 Activation shh Mutant <br />  <br />  <br />  <br />  <br /> PLoS | www.plosone.org   12   October 2010 | Volume 5 | Issue 10 | e13549 <br />                                                                                                                             p53 Activation shh Mutant <br />  <br />  <br />  <br /> Figure 9. p53 loss rescues amacrine photoreceptor cells shh2/2 mutant retina. Differentiation retinal cell types assessed <br /> using specific antibodies   B). sections oriented anterior  sections stained phalloidin-Alexa568    <br /> u; B, f) visualize retinal lamination. Staining HuC neuronal antigen labelled ganglion amacrine cells wild-type retina   , ganglion amacrine cells shh2/2 mutant retina   b). p532/2shh2/2 retina,  labelling ganglion cells amacrine <br /> cells partially restored   c). Ganglion cells labelled anti-zn5 antibody present comparable numbers wild-type   d), shh2/2 <br /> mutant   e) p532/2shh2/2 mutant retinas   f). Amacrine cells labelled anti-parvalbumine antibody present wild-type retina   <br /> g), absent shh2/2 mutant   h) partially rescued p532/2shh2/2 mutant retina   . Red-green double cones (zpr1 antibody <br /> labelling) rod photoreceptors (zpr3 antibody labeling) present wild-type retina   j, m), absent shh2/2 mutant retina   k, n) rescued p532/2shh2/2 mutant retina   l, o). Staining glutamine synthetase (GS) labelled Mu&#194;&#168;ller glia cells wild-type embryos   p). shh2/2 p532/2shh2/2 retinas, Mu&#194;&#168;ller glia present   q, r). Bipolar cells labelled wild-type retina anti-PKCa <br /> antibody staining   s), absent shh2/2 p532/2shh2/2 retinas   t, u). 5 dpf, Mu&#194;&#168;ller glia bipolar cells detected shh2/2 p532/2shh2/2 retinas (B, b,c,e,f) lower numbers wild-type retina (B, d). stainings performed 6 embryos genotype representative images shown. (C) Quantitation rescue amacrine cells (parvalbumine labelling), red-green double cone (zpr1) rod photoreceptors (zpr3) p532/2shh2/2 mutant retina plotting ratios segmented area staining total retina area. <br /> Amacrine cells occupy significantly larger relative area wild-type p532/2shh2/2 mutant retina (* bars, t-test, P- <br /> value,0,05), relative areas types photoreceptors significantly different wild-type p532/2shh2/2 mutant retinas. <br /> doi:10.1371/journal.pone.0013549.g009 <br />  <br /> Shh (Figs. 1, 2). expression EGFP-bcl2 [54] suppressed                   expression elevated apoptosis detected somites elevated apoptosis shh2/2 mutant showing intrinsic                   shh2/2 mutant (Fig. 5D), p53 mediate apoptosis apoptotic pathway activated. determined onset              somites shh2/2 mutant earlier stages, make <br /> p53 pathway activation elevated apoptosis shh2/2                      elevated p53 reporter expression fully consistent role <br /> mutant happened 10somite stage (Fig. S2). broad                    Shh sclerotome cell survival myogenic differentiation [7]. <br /> pattern p53 target gene expression apoptosis shh2/2                Locations p53 reporter-positive cells lateral midbrain mutant 10somite stage argues cell death                        suggestive neural crest origin (Fig. 5), agreeing differentiation failure, cells wild-type embryos                requirement Shh survival [10]. Taken  express neuronal differentiation marker HuC stage [55].                  results high expression p53 reporter transgenic  early requirement Shh cell survival                      reporter regions requiring Shh cell survival development consistent observations neural               advantages p53 reporter situ hybridizations p53 <br /> tube Hh signaling regulates cell survival independently                 target genes antibody stainings p53 [48] thanks earlier effects cell fate [13].                                      possibility live imaging, label specific cell parts change <br />                                                                                  fluorescent protein used labeling. <br /> PG13p21::nlsEGFP transgenic line faithfully reports <br /> regions p53 activation                                                      Activation Hh signalling suppresses p53 pathway    detect cells undergone p53 activation,                         shh2/2 mutant <br /> constructed PG13p21::nlsEGFP transgenic p53 reporter.                            Activation p53 absence Shh raises question <br /> Expression reporter shh2/2 mutant dependent                    elevated p53 activity suppressed Hh <br /> p53, inducible roscovitine localised activeCaspase3               signaling activation.  Hh signaling activation using <br /> labeling shh2/2 mutant 56 hpf (Fig. 4) suggesting             dnPKA-GFP effectively suppressed p53 target gene expression <br /> PG13p21::nlsEGFP line bona fide p53 reporter.                               apoptosis shh2/2 mutant 12somite stage (Fig. 6). <br />    Expression p53 reporter shh2/2 mutant retina 24                  study progress, Abe et al. (2008) suggested <br /> hpf higher wild-type retina apoptotic               Hh signaling regulates stability p53 activating Mdm2 cells detected cases (Fig. 5), suggesting                      human cell lines inducing unknown Mdm2-activating factor <br /> extraretinal Shh controls p53 activity early retinal                      [18]. Stecca Altaba (2009) characterized interaction <br /> development onset Shh production retina                  p53 Gli1, downstream Hh signalling effector, 28 hpf [49].  56 hpf, apoptotic cells p53 reporter-               wild-type mouse neural stem cells [19]. authors positive cells present retina indicating delay                 Gli1 suppress p53 activity regulating Mdm2 level. initial p53 activation apoptosis induction                    p53 activity inhibited Hh signaling activation human <br /> shh2/2 mutant retina probably high level pro-survival <br />                                                                                  cell lines, mouse neural stem cells zebrafish embryos, factors early retina. Extraretinal Hh signalling known                                                                                  mechanism likely involved. required early retinal patterning, example, Stenkamp <br />                                                                                      Concerning p53 regulation, question Hh signaling Frey (2003) showed inhibition Hh signalling 10 <br />                                                                                  required establishment maintenance p53 activity control. <br /> hpf reduces ath5 retinal patterning gene expression stronger                                                                                  Given localized nature Shh expression, cells perceiving Shh treatments retinal neurogenesis [56], Kay <br />                                                                                  signal unlikely require persistent Shh signaling control authors (2005) demonstrated Hh signalling inhibition <br />                                                                                  p53 activity, certain period development. 13 hpf 25 hpf delay expression ath5 [57]. <br />                                                                                  Shh clearly required establish control p53 activity  Masai et al. (2005) using forskolin, activator PKA, Hh signalling 22&#226;&#8364;&#8220;26 hpf period essential                 p53 activated late gastrulation [40], ath5 expression wave, highlighting role extraretinal Hh              earlier 10somite stage.  onset signalling retinal patterning [36]. findings consistent               Shh expression, control p53 pathway appears studies, implicate extraretinal Hh signalling             dependent Shh signaling. <br /> regulation p53 activity retina. <br />    addition, observed p53 reporter activation apoptosis              Regulation retinal cell proliferation p53 midbrain, hindbrain spinal cord regions neural tube               shh2/2 mutant <br /> (Fig. 5), consistent previous studies survival                     p53 loss shh2/2 mutant rescues aspects retinal <br /> function Shh tissues [6,9]. p53 reporter                    proliferation: cell-cycle exit retinal cell progenitors (Fig. 8)  <br />  <br />        PLoS | www.plosone.org                                           13                          October 2010 | Volume 5 | Issue 10 | e13549 <br />                                                                                                                          p53 Activation shh Mutant <br />  <br />  mitotic indices neurogenesis (Fig. 7).                    bipolar cells [68]. context, p27Xic1 interacts functionally  expression cyclin-dependent kinase inhibitor                   Notch/Delta signalling proneural genes Xath5 p57kip2 induced p532/2shh2/2 mutant retina (Fig. 8C)                  precisely regulate neurogenesis sequence [69,70]. Consistent arguing normal cell-cycle exit. normal mitotic index               lack amacrine cells shh2/2 mutant, mouse p57Kip2 p532/2shh2/2 mutant retina neurogenesis (24 hpf) likely               involved development subset amacrine cells [71]. result lack p53-activated cell cycle inhibitory gene                    Regulation cell death powerful mechanism known <br /> expression, rescue cell-cycle exit normal mitotic              shape organs. studies zebrafish mutants addressed <br /> indices retina neurogenesis lack               suppression p53-mediated apoptosis affects retinal cell-cycle inhibitor expression mitoses differenti-              differentiation. mutants DNA polymerase delta 1 subunit <br /> ating cells cell-cycle exit. Previous studies cell-cycle exit        (pold1), suppression apoptosis retina p53 knockdown zebrafish retina [35,36] showed Hh signalling essential             rescues eye size morphology [72] primase1 mutant, p57kip2 expression retina. support conclusion             p53 knockdown led rescue amacrine cell propose Shh signalling regulates retinal expression p57kip2             photoreceptor differentiation [73]. contrast, p53 knockdown controlling activity p53.                                                 chromatin assembly factor 1b mutant didn&#226;&#8364;&#8482;t improve retinal    p53-mediated Notch1 expression responsible failure                cartilage differentiation [74], gene required shh2/2 mutant embryos express p57kip2. Notch1 p53                    cell survival differentiation cell types. Rescue target human keratinocytes [58] myeloid lymphoid                     amacrine cells photoreceptors p53 loss shh2/2 <br /> cells [59].  bioinformatic analyses suggest Gli2              mutant retina similar p53 knockdown results pold1 prevent p53 activating Notch1 gene expression,                 primase1 mutants, Shh likely affects differentiation connection p53, Hh Notch pathways [60].                     regulating p53 activity mechanisms, zebrafish, Notch1 homologs likely p53 targets              mutations pold1 primase1 proposed induce genotoxic contain optimal p53 binding sites (unpublished results). Notch             damage. studies identified context-dependence p53 <br /> signaling inhibits p57kip2 expression zebrafish neural tube              effects differentiation, example, p53 promotes differentia- <br /> development [61], mouse pancreas development [62],                    tion mouse embryonic stem cells DNA damage adult mouse intestinal crypts [63] eye lense                     decreasing Nanog expression [75] reduces spontaneous <br /> development mouse [64]. p53 blocks retinal cell-                 differentiation human stem cells [76]. <br /> cycle exit absence shh activating Notch signalling undoubtedly uncovered future studies.                                     Conclusions <br />                                                                                    results identify p53 pathway essential mediator Coordinate regulation cell cycle, cell survival                          elevated apoptosis developing nervous retina <br /> differentiation retina                                                   absence Shh zebrafish. Shh signalling <br />    study shows p53 inhibits generation amacrine                promotes cell survival context inhibiting p53 pathway. photoreceptor cells shh2/2 mutant retina, raising question             retina, Shh controls p53 regulate cell survival p53 loss essential survival               proliferation, shh mutant loss p53 suppresses elevated <br /> differentiation. data suggest shh2/2 mutant, p53 loss            apoptosis, leads normal mitotic indices retina rescues essential survival cell-cycle exit retinal                   cell-cycle exit. Control p53 Shh essential progenitors, occur cells differentiate.                differentiation amacrine cells photoreceptors. <br /> contrast, differentiation ganglion cells, bipolar Mu&#194;&#168;ller glia <br /> cells shh2/2 mutant retina affected p53 suggesting                Materials Methods Shh signalling promotes retinal differentiation controlling p53 activity p53-independent                      Fish stocks, maintenance, identification care <br /> mechanisms.                                                                        Wild-type WIK, sonic-yout4 [77] p53zdf1 [44] heterozygous <br />    retinal progenitor cells, differentiation decisions               fish used. Fish maintained according standard <br /> coupled regulation cell cycle. study shown p53              protocols. Embryos grown E3 embryo medium 28uC <br /> affects retinal cell cycle differentiation phenotypes           addition 0.003% 1-phenyl-2-thiourea <br /> shh2/2 mutant embryos implicating p53 pathway coupling                    (Sigma) inhibit pigmentation. Staging performed according <br /> cell cycle regulation differentiation retina. studies          hours post-fertilization (hpf) [78]. Identification p53 genotype <br /> identified mechanisms coordinating cell cycle                   performed according published protocol [44]. Fin clips <br /> differentiation decisions retina. Retinoblastoma 1 (Rb1)                 obtained anesthesizing adult fish 0.02% Tricaine promotes retinal differentiation inhibition E2f1                cutting small pieces caudal fin. DNA samples E2f3a loss developing mouse retina leads                  identification prepared described previously [79]. sonic- <br /> ectopic proliferation elevated apoptosis rescued E2f1 loss               yout4 mutants identified curled body shape U- <br /> [65]. functional analogy Rb1-E2f Shh-p53                 shaped somites. <br /> interactions, Rb1 Shh required proper cell cycle <br /> regulation, differentiation control E2f factors p53,                 Morpholino mRNA microinjection procedures <br /> respectively. contrast, postnatal mouse retina, Rb                   p53 morpholino (GCGCCATTGCTTTGCAAGAATTG, [42]) proposed promote rod photoreceptor differentiation                      mismatch control p53 morpholino (GCA CCA TCG activation Nrl transcription factor [66]. CDK inhibitors             CTT GGC AAG CAT TG) [72] purchased Gene <br /> (CDKI) essential cell-cycle exit retinal progenitors,            Tools injected 1-cell stage 0.5 mM. make RNA known regulate differentiation cell-cycle                     expression experiments, required pCS2+ vectors linear- <br /> independent mechanisms, importance CDKI-mediated cell                    ised transcribed using mMessage mMachine SP6 (Ambion, cat <br /> cycle inhibition unclear (reviewed [67]). Studies             # AM1340). following plasmids used prepare <br /> Ohnuma colleagues showed p27Xic1, Xenopus CDK                        RNA microinjections: pCS2+dnPKA-GFP [51], pCS2+EGFP, <br /> inhibitor, promotes generation Mu&#194;&#168;ller glia expense                pCS2+EGFP-bcl2 [54], pCS2+FA Transposase (Tol2kit). <br />  <br />  <br />        PLoS | www.plosone.org                                          14                         October 2010 | Volume 5 | Issue 10 | e13549 <br />                                                                                                                           p53 Activation shh Mutant <br />  <br />  <br />  <br /> Generation PG13p21::nlsEGFP p53 reporter line                            BrdU labelling <br />    Human CDKN1A/p21 2.4 kb promoter amplified                             Embryos anesthesized 0.02% Tricaine injected <br /> RPCI-11 Human BAC clone (Imagenes, RPCIB753F15397Q)                             small drop (5&#226;&#8364;&#8220;10 nl) 10 mM 5-Bromodeoxyuridine <br /> using following primers:                                                    (BrdU) yolk sac. injection, embryos allowed    HindIII_p21prom_for AAGCTTGGGCACTCTTGTCCCC-                                  develop required period time fixed PFA analysis. <br /> CAGG                                                                            BrdU-labeled embryo cryosectioned sections <br />    BamHI_p21prom_rev GGATCCCTGACTTCGGCAGCTGC-                                   dried, washed PBST (PBS + 0.1% Tween20 (Sigma, cat# <br /> TCA                                                                             P9416)), incubated 2N HCl 10 minutes 23uC    resulting PCR product TOPO-cloned pCR2.1                        transferred 37uC 30 minutes washed (Invitrogen) subcloned p5E-MCS vector using                   PBST. Anti-BrdU staining described HindIII BamHI restriction sites make p5E-p21 vector.                     section Materials Methods, sections finally stained <br /> PG13 enhancer (13 copies optimal p53 binding site                         20 mg/ml DAPI. Quantification BrdU-positive nuclei <br /> CCTGCCTGGACTTGCCTGG) [46] ordered GEN-                                 using &#226;&#8364;&#732;&#226;&#8364;&#732;Colocalization Threshold&#226;&#8364;&#8482;&#226;&#8364;&#8482; analysis BrdU EART AG (custom product). synthetic PG13 fragment                           DAPI signals &#226;&#8364;&#732;&#226;&#8364;&#732;Cell Counter&#226;&#8364;&#8482;&#226;&#8364;&#8482; plugins Fiji software (http:// <br /> contained KpnI HindIII restriction sites directional                    pacific.<span id='am-1' about='obo:IMR_0001651' typeof='owl:Thing obo:IMR_0001650 obo:IMR_0001356 obo:IMR_0000947 obo:IMR_0001382 obo:IMR_0000001 obo:IMR_0001384 obo:IMR_0001362'><span id='am-2' property="oboInOwl:hasExactSynonym" content="MPI" datatype="xsd:string"></span><span id='am-3' property="oboInOwl:hasExactSynonym" content="phosphoinositide" datatype="xsd:string"></span><span id='am-4' property="rdfs:label" content="monophosphoinositide" datatype="xsd:string"></span><span id='am-5' property="rdfs:label" content="MPI" datatype="xsd:string"></span><span id='am-6' property="oboInOwl:hasOBONamespace" content="molecule_role" datatype="xsd:string"></span><span id='am-7' property="oboInOwl:hasExactSynonym" content="monophosphoinositide" datatype="xsd:string"></span><span id='am-8' property="oboInOwl:hasExactSynonym" content="inositol phosphoglyceride" datatype="xsd:string"></span><span id='am-9' property="rdfs:label" content="phosphoinositide" datatype="xsd:string"></span><span id='am-10' property="rdfs:label" content="phosphatidylinositol" datatype="xsd:string"></span><span id='am-11' property="oboInOwl:id" content="IMR:0001651" datatype="xsd:string"></span><span id='am-12' property="rdfs:label" content="inositol phosphoglyceride" datatype="xsd:string"></span><span id='am-13' property="oboInOwl:hasDbXref" content="KEGG:C00626" datatype="xsd:string"></span>mpi</span>-cbg  described  <br /> cloning p5E-p21. Insertion PG13 p5E-p21 resulted final 59-entry vector p5E-PG13p21. generate                         Immunohistochemical methods <br /> pDestCG2-PG13p21::nlsEGFP-polyA, p5E-PG13p21 recom-                            Antibody stainings cryosections described <br /> bined pME-nlsEGFP, p3E-polyA pDestCG2 vectors                          [35]. following antibodies used: anti-zn5, anti- <br /> (Tol2kit, [47]). construct injected wild-type                 zpr1, anti-zpr3 1:100 dilution (Developmental Studies Hybrid- <br /> embryos, raised adulthood identified                       oma Bank), anti-parvalbumine &#226;&#8364;&#8220; Chemicon (MAB1572) 1:200 <br /> transgenic founders.                                                            dilution, anti-GAD67 &#226;&#8364;&#8220; Chemicon (AB5862P) 1:100 dilution, <br />                                                                                 anti-glutamine synthetase &#226;&#8364;&#8220; BD Biosciences (cat# 610517) situ hybridisation probe synthesis                                       1:500 dilution, anti-PKCa &#226;&#8364;&#8220; Santa Cruz Biotechnology (sc-208)    RNA situ hybridisations performed according Jowett                1:100 dilution, anti-HuC &#226;&#8364;&#8220; Molecular Probes  21271), anti-GFP <br /> (2001) [80]. Probes using Roche DIG RNA Labeling                      &#226;&#8364;&#8220; Molecular Probes, Invitrogen (A11122) 1:200 dilution, anti- <br /> Kit (Cat # 11175025910). fragments p53, puma, p21, bcl2,                 BrdU &#226;&#8364;&#8220; Sigma (cat# B8434) 1:100 dilution, anti-pH3-S10 &#226;&#8364;&#8220; <br /> mcl1a, mcl1b cloned pCR4 vector (Invitrogen) using                Abcam (ab5176-100) 1:400 dilution, anti-activeCaspase3 &#226;&#8364;&#8220; BD <br /> primers listed Table 1. Plasmids containing cyclinG1 cDNA                    Pharmingen (cat# 557035) 1:200 dilution. Secondary anti- <br /> (pCMV-SPORT6.1-cyclinG1 (Imagenes)), mdm2 cDNA (pME-                            mouse Alexa Fluor 488 antibody (1:400) (Invitrogen, cat# <br /> 18S-FL3 &#226;&#8364;&#8220; mdm2 (Imagenes)), bax1 cDNA (pME-18S-FL3 &#226;&#8364;&#8220; bax1                       A11001), anti-rabbit Alexa Fluor 488 (1:400) (Invitrogen, cat# <br /> (Imagenes)) bcl2l (pDNR-LIB-bcl2l (Imagenes)) used                 11008) anti-rabbit Alexa Fluor 594 (1:400) (Invitrogen, <br /> making templates vitro transcription using primers listed             cat# 11012) diluted blocking solution incubated Table 1. Probes p57 patched1 using previously                 sections 2 hours. label actin structures, Alexa Fluor 568 <br /> published plasmids [35,81].                                                     labeled phalloidin (Invitrogen, A12380) diluted 1:400  <br />  Table 1. Primers used amplify cDNA fragments. <br />  <br />  <br />  Primer_ <br />        _name                             Sequence                                                         Template PCR <br />  <br />  mcl1a_for                               tatggctttgagtttggattttagg                                        cDNA <br />  mcl1a_rev                               gcattgatagccattggc                                               cDNA <br />  mcl1b_for                               gagaagaagaaaaaatgtagagttg                                        cDNA <br />  mcl1b_rev                               agcacttcgaaaaggaaaa                                              cDNA <br />  bcl2l_for                               tggataaccgtattaccgcc                                             pDNR-LIB-bcl2l (ZFIN) <br />  T3_bcl2l_rev                            cgcgcaattaaccctcactaaagcactagtcataccaggatc                       pDNR-LIB-bcl2l (ZFIN) <br />  bcl2_for                                gcgcgtttctatcgtgattt                                             cDNA <br />  bcl2_rev                                agcatgtgtgcacgtgtttt                                             cDNA <br />  bax1_for                                tgtacggaagtgttacttctgctc                                         pME18S-FL3-bax1(ZFIN) <br />  T3_bax1_rev                             ggatccattaaccctcactaaagggaaggccgcgacctgcagctc                    pME18S-FL3-bax1(ZFIN) <br />  p53_for                                 gaatccccaaaactccacgc                                             cDNA <br />  p53_rev                                 ccaaaaagagcaaaactccc                                             cDNA <br />  pME_for                                 attaaccctcactaaaggctgctcctcagtggatgttgcctttac                    pME18S-FL3-mdm2 (Imagenes) <br />  T7_pME_rev                              taatacgactcactataggcaggttcagggggaggtgtgg                         pME18S-FL3-mdm2 (Imagenes) <br />  puma_for                                aacaccgctttatatcccct                                             cDNA <br />  puma_rev                                tgtgttcatctgaggccgtg                                             cDNA <br />  p21_for                                 tcaggtgttcctcagctcct                                             cDNA <br />  p21_rev                                 cggaataaacggtgtcgtct                                             cDNA <br />  <br />  doi:10.1371/journal.pone.0013549.t001 <br />  <br />  <br />  <br />        PLoS | www.plosone.org                                          15                        October 2010 | Volume 5 | Issue 10 | e13549 <br />                                                                                                                            p53 Activation shh Mutant <br />  <br />  <br /> blocking buffer added secondary antibody solutions. Images              threshold images experiment taken using Leica SP2 confocal microscope processed                   manually chosen optimal segmentation signal. <br /> using Adobe Creative Suite CS4.                                                Thresholded images segmented using Analyze <br />                                                                                Particles plugin (Analyze Analyze Particles), outputs localisation analysis                                                       area segmented signal. <br />    localisation analysed using &#226;&#8364;&#732;&#226;&#8364;&#732;Colocalisation Threshold&#226;&#8364;&#8482;&#226;&#8364;&#8482; <br /> plugin Fiji software. plugin takes images outputs               Statistical analyses statistics including percent localised pixels relative           differences cell proportions counts statistically <br /> total pixels localising channels image,               evaluated using Student&#226;&#8364;&#8482;s t-test Microsoft Excel 2007. qPCR pixels present images white.                                 data initially processed using SDS1.2 software                                                                                Applied Biosystems obtain Ct values, amplification <br /> Apoptosis assays                                                               cycle number reaction reaches certain threshold   ApopTag staining performed using Chemicon ApopTag                        expression. Relative gene expression calculated using Peroxidase situ apoptosis detection kit (Cat # S7100)                    DDCt method ([82]) assuming equal amplification efficiencies. Ct <br /> described [74]. TUNEL staining cryosections                      values samples normalised reference gene expression <br /> performed described [35] using TUNEL-TMR-Red kit                     average wild-type gene expression converted <br /> (Roche, cat # 1966006001).                                                     fold expression differences. Student&#226;&#8364;&#8482;s t-test applied                                                                                fold expression differences (p,0.05 set significance level). <br /> qPCR semi-quantitative PCR assays                                          Statistical significance embryo proportions Hedgehog <br />    RNA embryos embryo heads purified using                   signalling activation experiment (Fig. 6) determined using <br /> RNeasy kit (Qiagen, cat# 74104) cDNA samples                          Fisher&#226;&#8364;&#8482;s exact test using fisher.test function R language <br /> prepared using Quantitect Reverse Transcription Kit (Qiagen,                   environment (R version 2.9.0). <br /> cat# 205311) used quantitative real-time PCR 20- <br /> fold dilution. SYBRH Green PCR Master Mix (Applied Biosys-                     Supporting Information <br /> tems, cat# 4309155) used prepare qPCR reactions, run ABI7500 qPCR machine. Primers used qPCR                    Figure S1 Expression anti-apoptotic Bcl2 family genes assays appropriate references listed Table 2. Semi-                 shh2/2 mutant versus wild-type zebrafish embryos 24 hpf. quantitative PCR length p53, D113 isoform b-actin             situ mount analysis bcl2, bcl2l, mcl1a mcl1b <br /> transcripts performed essentially described [38].                expression shh2/2 mutant wild-type embryos 24 hpf. <br />                                                                                 doi:10.1371/journal.pone.0013549.s001 (3.22 MB TIF) <br /> Counting procedure                                                             Figure S2     Onset increased p53 expression apoptosis   TUNEL-positive, DAPI-stained nuclei pH 3-labelled cells                  shh2/2 mutant occurs somitogenesis. p53 situ used counted manually using Cell Counter plugin ImageJ,                 identify time points activated p53 protein   B, E, F,  J, allows labelling counted objects automatically               M, N, R, S, V, W). ApopTag staining used assay records number.                                                          apoptosis (C, D, G, H, K, L, P, Q, T, U, X, Y). following <br />                                                                                stages analysed 1somite  D), 6somite (E&#226;&#8364;&#8220;H), 8somite  L), <br /> Image quantification                                                           10somite (M&#226;&#8364;&#8220;Q), 12somite (R&#226;&#8364;&#8220;U), 14somite (V&#226;&#8364;&#8220;Y). early stages <br />    Image quantification Figs. 2A-B Fig.9 using Fiji            possible identify embryos (wild-type shh2/2). <br /> software. quantify area particular signal image, raw           10somite stage, shh2/2 mutant embryos RGB images split channels, single channel images                 identified based p53 expression ApopTag staining processed remove irrelevant parts image (select             quarter batch. stainings Edit Clear Outside). processed images thresholded,                repeated times 40 embryos analysed                                                                                staining. <br />                                                                                 doi:10.1371/journal.pone.0013549.s002 (5.97 MB TIF) <br />  Table 2. Primers qPCR assays. <br />                                                                                Figure S3      Normal differentiation retinal cell types p532/2 <br />                                                                                mutant. Antibody staining retinal cryosections p532/2 <br />  Primer             Sequence                          Source                   mutant embryos 72 hpf. Anterior sections  p53q_for           cccatcctcacaatcatcact             study               images. Phalloidin-Alexa568 used label actin <br />  p53q_rev           cacgcacctcaaaagacctc              study <br />                                                                                structures. images normal differentiation ganglion <br />                                                                                cells (zn-5), amacrine cells (GAD67 parvalbumin), Mu&#194;&#168;ller glia <br />  p21_qfor           agctgcattcgtctcgtagc              [72] <br />                                                                                (glutamine synthetase (GS)), bipolar cells (Protein kinase C  p21_qrev           tgagaacttactggcagcttca            [72]                     (PKCa)) photoreceptors (zpr1 zpr3). <br />  mdm2q_for          gatgcaggtgcagataaagatg            study                doi:10.1371/journal.pone.0013549.s003 (3.13 MB TIF) <br />  mdm2q_rev          ccttgctcatgatatatttccctaa         study <br />  cycG1-qfor         catctctaaaagaggctctagatgg         study               Acknowledgments <br />  cycG1-qrev         cacacaaaccaggtctccag              study               like thank PhD supervisor Carl Neumann  bax1_qfor          gcaagttcaactggggaaga              study               suggesting work apoptosis shh mutant Darren Gilmour <br />                                                                                valuable comments suggestions providing Tol2 kit plasmids, <br />  bax1_qrev          gtcaggaaccctggttgaaa              study <br />                                                                                originally gift Chi-Bin Chien. grateful p53 mutant <br />  gapdh_qfor         tgcgttcgtctctgtagatgt             [40]                     fish, gift Stefan Schulte-Merker. particular gratitude goes  gapdh_qrev         gcctgtggagtgacactga               [40]                     Francesca Peri critical reading manuscript providing working <br />                                                                                environment support finishing stage project.  doi:10.1371/journal.pone.0013549.t002                                         like acknowledge helpful comments Dirk Sieger  <br />  <br />        PLoS | www.plosone.org                                         16                           October 2010 | Volume 5 | Issue 10 | e13549 <br />                                                                                                                                                   p53 Activation shh Mutant <br />  <br />  <br /> manuscript.  want thank Gill Brunt Sandra Gandre&#194;&#180;                         Conceived designed experiments: SVP. Performed experi- <br /> fish care.                                                                                     ments: SVP. Analyzed data: SVP. Contributed reagents/materials/ <br />                                                                                                analysis tools: SVP. Wrote paper: SVP. <br /> Author Contributions <br />  <br /> References <br />  1. Ingham PW, McMahon AP (2001) Hedgehog signaling animal development:                     30. Levine EM, Roelink H, Turner J, Reh TA (1997) Sonic hedgehog promotes rod <br />     paradigms principles. Genes Development 15: 3059&#226;&#8364;&#8220;3087.                                 photoreceptor differentiation mammalian retinal cells vitro. J Neurosci 17: <br />  2. Ruiz Altaba  Nguye&#203;&#8224;n V, Palma V (2003) emergent design neural                   6277&#226;&#8364;&#8220;6288. <br />     tube: prepattern, SHH morphogen GLI code. Curr Opin Genet Dev 13:                      31. Moshiri  McGuire CR, Reh TA (2005) Sonic hedgehog regulates proliferation <br />     513&#226;&#8364;&#8220;521.                                                                                       retinal ciliary marginal zone posthatch chicks. Dev Dyn 233: 66&#226;&#8364;&#8220;75. <br />  3. Jiang J, Hui CC (2008) Hedgehog signaling development cancer. Dev                   32. Wang Y, Dakubo GD, Thurig S, Mazerolle CJ, Wallace VA (2005) Retinal <br />     Cell 15: 801&#226;&#8364;&#8220;812.                                                                              ganglion cell-derived sonic hedgehog locally controls proliferation timing <br />  4. Varjosalo M, Taipale J (2008) Hedgehog: functions mechanisms. Genes Dev                    RGC development embryonic mouse retina. Development 132: <br />     22: 2454&#226;&#8364;&#8220;2472.                                                                                 5103&#226;&#8364;&#8220;5113. <br />  5. Cai C, Thorne J, Grabel L (2008) Hedgehog serves mitogen survival                 33. Locker M, Agathocleous M, Amato MA, Parain K, Harris WA, et al. (2006) <br />     factor embryonic stem cell neurogenesis. Stem Cells 26: 1097&#226;&#8364;&#8220;1108.                      Hedgehog signaling retina: insights mechanisms controlling  6. Charrier JB, Lapointe F, Le Douarin NM, Teillet MA (2001) Anti-apoptotic role                  proliferative properties neural precursors. Genes Dev 20: 3036&#226;&#8364;&#8220;3048. <br />     Sonic hedgehog protein early stages nervous organogenesis.             34. Neumann CJ (2005) Hedgehogs negative regulators cell cycle. Cell <br />     Development 128: 4011&#226;&#8364;&#8220;4020.                                                                    Cycle 4: 1139&#226;&#8364;&#8220;1140. <br />  7. Borycki AG, Brunk B, Tajbakhsh S, Buckingham M, Chiang C, et al. (1999)                    35. Shkumatava  Neumann CJ (2005) Shh directs cell-cycle exit activating <br />                                                                                                    p57Kip2 zebrafish retina. EMBO Reports. pp 563&#226;&#8364;&#8220;569. <br />     Sonic hedgehog controls epaxial muscle determination Myf5 activation. <br />                                                                                                36. Masai  Yamaguchi M, Tonou-Fujimori N, Komori  Okamoto H (2005)     Development 126: 4053&#226;&#8364;&#8220;4063. <br />                                                                                                    hedgehog-PKA pathway regulates distinct steps differentiation  8. Litingtung Y, Chiang C (2000) Specification ventral neuron types mediated <br />                                                                                                    retinal ganglion cells: cell-cycle exit retinoblasts neuronal <br />     antagonistic interaction Shh Gli3. Nat Neurosci 3: 979&#226;&#8364;&#8220;985. <br />                                                                                                    maturation. Development 132: 1539&#226;&#8364;&#8220;1553. <br />  9. Britto J, Tannahill D, Keynes R (2002) critical role sonic hedgehog <br />                                                                                                37. Chen J, Ruan H, Ng SM, Gao C, Soo HM, et al. (2005) Loss function def <br />     signaling early expansion developing brain. Nat Neurosci 5:                      selectively regulates Delta113p53 expression arrest expansion growth     103&#226;&#8364;&#8220;110.                                                                                       digestive organs zebrafish. Genes Dev 19: 2900&#226;&#8364;&#8220;2911. <br /> 10. Ahlgren SC, Bronner-Fraser M (1999) Inhibition sonic hedgehog signaling              38. Robu  Larson JD, Nasevicius  Beiraghi S, Brenner C, et al. (2007) p53 <br />     vivo results craniofacial neural crest cell death. Current Biology 9: 1304&#226;&#8364;&#8220;1314.            activation knockdown technologies. PLoS Genetics 3: e78. <br /> 11. Jeong J, Mao J, Tenzen T, Kottmann AH, McMahon AP (2004) Hedgehog                          39. Nakano K, Vousden KH (2001) PUMA, novel proapoptotic gene, induced <br />     signaling neural crest cells regulates patterning growth facial              p53. Mol Cell 7: 683&#226;&#8364;&#8220;694. <br />     primordia. Genes Development 18: 937&#226;&#8364;&#8220;951.                                              40. Kratz E, Eimon PM, Mukhyala K, Stern H, Zha J, et al. (2006) Functional <br /> 12. Stenkamp DL, Frey RA, Mallory  Shupe EE (2002) Embryonic retinal gene                       characterization Bcl-2 gene family zebrafish. Cell Death <br />     expression sonic mutant zebrafish. Dev Dyn 225: 344&#226;&#8364;&#8220;350.                                Differentiation 10: 1631&#226;&#8364;&#8220;1640. <br /> 13. Cayuso J, Ulloa F, Cox B, Briscoe J, Mart&#196;&#177;&#194;&#180; E (2006) Sonic hedgehog                    41. Nasevicius  Ekker SC (2000) Effective targeted gene &#226;&#8364;&#732;knockdown&#226;&#8364;&#8482; zebrafish. <br />     pathway independently controls patterning, proliferation survival                   Nat Genet 26: 216&#226;&#8364;&#8220;220. <br />     neuroepithelial cells regulating Gli activity. Development 133: 517&#226;&#8364;&#8220;528.                42. Langheinrich U, Hennen E, Stott G, Vacun G (2002) Zebrafish model <br /> 14. Bigelow RL, Chari NS, Unden AB, Spurgers KB, Lee S, et al. (2004)                              organism identification characterization drugs genes affecting <br />     Transcriptional regulation bcl-2 mediated sonic hedgehog signaling                   p53 signaling. Curr Biol 12: 2023&#226;&#8364;&#8220;2028. <br />     pathway gli-1. Journal Biological Chemistry 279: 1197&#226;&#8364;&#8220;1205.                     43. Michalak E, Villunger  Erlacher M, Strasser (2005) Death squads enlisted <br /> 15. Thibert C, Teillet MA, Lapointe F, Mazelin L, Le Douarin NM, et al. (2003)                     tumour suppressor p53. Biochem Biophys Res Commun 331: 786&#226;&#8364;&#8220;798. <br />     Inhibition neuroepithelial patched-induced apoptosis sonic hedgehog.                 44. Berghmans S, Murphey RD, Wienholds E, Neuberg D, Kutok JL, et al. (2005) <br />     Science 301: 843&#226;&#8364;&#8220;846.                                                                          tp53 mutant zebrafish develop malignant peripheral nerve sheath tumors. Proc <br /> 16. Chao MV (2003) Dependence receptors: mechanism? Sci STKE                           Natl Acad Sci USA 102: 407&#226;&#8364;&#8220;412. <br />     2003: PE38.                                                                                45. Zhang WW, Labrecque S, Azoulay E, Dudley R, Matlashewski G (2001) <br /> 17. Guerrero  Ruiz Altaba (2003) Development. Longing ligand: hedgehog,                  Development p53 responsive GFP reporter; identification live cells     patched, cell death. Science 301: 774&#226;&#8364;&#8220;776.                                                 p53 activity. J Biotechnol 84: 79&#226;&#8364;&#8220;86. <br /> 18. Abe Y, Oda-Sato E, Tobiume K, Kawauchi K, Taya Y, et al. (2008) Hedgehog                   46. Kern S, Pietenpol J, Thiagalingam S, Seymour  Kinzler K, et al. (1992) <br />     signaling overrides p53-mediated tumor suppression activating Mdm2. Proc                    Oncogenic forms p53 inhibit p53 regulated gene expression. Science 256: <br />     Natl Acad Sci USA 105: 4838&#226;&#8364;&#8220;4843.                                                              827&#226;&#8364;&#8220;830. <br /> 19. Stecca B, Ruiz Altaba (2009) GLI1-p53 inhibitory loop controls neural                47. Kwan KM, Fujimoto E, Grabher C, Mangum BD, Hardy  et al. (2007)     stem cell tumour cell numbers. EMBO J 28: 663&#226;&#8364;&#8220;676.                                         Tol2kit: multisite gateway-based construction kit Tol2 transposon <br /> 20. Fan H, Khavari PA (1999) Sonic hedgehog opposes epithelial cell cycle arrest.                  transgenesis constructs. Dev Dyn 236: 3088&#226;&#8364;&#8220;3099. <br />     J Cell Biol 147: 71&#226;&#8364;&#8220;76.                                                                    48. Lee KC, Goh WL, Xu M, Kua N, Lunny D, et al. (2008) Detection p53 <br /> 21. Dahmane N, Ruiz Altaba (1999) Sonic hedgehog regulates growth                      response zebrafish embryos using new monoclonal antibodies. Oncogene 27: <br />     patterning cerebellum. Development 126: 3089&#226;&#8364;&#8220;3100.                                      629&#226;&#8364;&#8220;640. <br />                                                                                                49. Neumann CJ, Nuesslein-Volhard C (2000) Patterning zebrafish retina 22. Wechsler-Reya RJ, Scott MP (1999) Control neuronal precursor proliferation <br />                                                                                                    wave sonic hedgehog activity. Science 289: 2137&#226;&#8364;&#8220;2139. <br />     cerebellum Sonic Hedgehog. Neuron 22: 103&#226;&#8364;&#8220;114. <br />                                                                                                50. Hammerschmidt M, Bitgood MJ, McMahon AP (1996) Protein kinase 23. Dahmane N, Sa&#194;&#180;nchez P, Gitton Y, Palma V, Sun T, et al. (2001) Sonic <br />                                                                                                    common negative regulator Hedgehog signaling vertebrate embryo. <br />     Hedgehog-Gli pathway regulates dorsal brain growth tumorigenesis. <br />                                                                                                    Genes Dev 10: 647&#226;&#8364;&#8220;658. <br />     Development 128: 5201&#226;&#8364;&#8220;5212. <br />                                                                                                51. Ungar AR, Moon RT (1996) Inhibition protein kinase phenocopies ectopic <br /> 24. Machold R, Hayashi S, Rutlin M, Muzumdar MD, Nery S, et al. (2003) Sonic                       expression hedgehog CNS wild-type cyclops mutant embryos. <br />     hedgehog required progenitor cell maintenance telencephalic stem cell                Dev Biol 178: 186&#226;&#8364;&#8220;191. <br />     niches. Neuron 39: 937&#226;&#8364;&#8220;950.                                                                52. Hendzel MJ, Wei Y, Mancini MA, Van Hooser  Ranalli T, et al. (1997) <br /> 25. Palma V, Lim DA, Dahmane N, Sa&#194;&#180;nchez P, Brionne TC, et al. (2005) Sonic                        Mitosis-specific phosphorylation histone H3 initiates primarily     hedgehog controls stem cell behavior postnatal adult brain.                         pericentromeric heterochromatin G2 spreads ordered fashion <br />     Development 132: 335&#226;&#8364;&#8220;344.                                                                      coincident mitotic chromosome condensation. Chromosoma 106: 348&#226;&#8364;&#8220;360. <br /> 26. Burke R, Basler, K (1996) Dpp receptors autonomously required cell                 53. Dierks C, Grbic J, Zirlik K, Beigi R, Englund NP, et al. (2007) Essential role     proliferation entire developing Drosophila wing. Development 122:                       stromally induced hedgehog signaling B-cell malignancies. Nat Med 13: <br />     2261&#226;&#8364;&#8220;2269.                                                                                     944&#226;&#8364;&#8220;951. <br /> 27. Mart&#196;&#177;&#194;&#180;n-Castellanos C, Edgar, B (2002) characterization effects Dpp          54. Langenau DM, Jette C, Berghmans S, Palomero T, Kanki JP, et al. (2005) <br />     signaling cell growth proliferation Drosophila wing. Development                 Suppression apoptosis bcl-2 overexpression lymphoid cells transgenic <br />     129: 1003&#226;&#8364;&#8220;1013.                                                                                zebrafish. Blood 105: 3278&#226;&#8364;&#8220;3285. <br /> 28. Duman-Scheel M, Weng L, Xin S, Du W (2002) Hedgehog regulates cell growth                  55. Kok FO, Oster E, Mentzer L, Hsieh JC, Henry CA, et al. (2007) role     proliferation inducing Cyclin D Cyclin E. Nature 417: 299&#226;&#8364;&#8220;304.                      SPT6 chromatin remodeling factor zebrafish embryogenesis. Dev Biol 307: <br /> 29. Jensen  Wallace VA (1997) Expression Sonic hedgehog putative                     214&#226;&#8364;&#8220;226. <br />     role precursor cell mitogen developing mouse retina. Development               56. Stenkamp DL, Frey RA (2003) Extraretinal retinal hedgehog signaling <br />     124: 363&#226;&#8364;&#8220;371.                                                                                  sequentially regulate retinal differentiation zebrafish. Dev Biol 258: 349&#226;&#8364;&#8220;363. <br />  <br />  <br />  <br />         PLoS | www.plosone.org                                                        17                              October 2010 | Volume 5 | Issue 10 | e13549 <br />                                                                                                                                                      p53 Activation shh Mutant <br />  <br />  <br /> 57. Kay JN, Link BA, Baier H (2005) Staggered cell-intrinsic timing ath5                      70. Vernon AE, Movassagh M, Horan  Wise H, Ohnuma S, et al. (2006) Notch <br />     expression underlies wave ganglion cell neurogenesis zebrafish                     targets Cdk inhibitor Xic1 regulate differentiation cell cycle     retina. Development 132: 2573&#226;&#8364;&#8220;2585.                                                              neurons. EMBO Rep 7: 643&#226;&#8364;&#8220;648. <br /> 58. Lefort K, Mandinova  Ostano P, Kolev V, Calpini V, et al. (2007) Notch1               71. Dyer MA, Cepko CL (2001) p57Kip2 cyclin kinase inhibitor expressed     p53 target gene involved human keratinocyte tumor suppression                         restricted set amacrine cells rodent retina. J Comp Neurol 429: <br />     negative regulation ROCK1/2 MRCKalpha kinases. Genes Dev 21:                              601&#226;&#8364;&#8220;614. <br />     562&#226;&#8364;&#8220;577.                                                                                     72. Plaster N, Sonntag C, Busse CE, Hammerschmidt M (2006) p53 deficiency <br /> 59. Secchiero P, Melloni E, di Iasio MG, Tiribelli M, Rimondi E, et al. (2009)                       rescues apoptosis differentiation multiple cell types zebrafish flathead <br />     Nutlin-3 upregulates expression Notch1 myeloid lymphoid                       mutants deficient zygotic DNA polymerase delta1. Cell Death Differentiation <br />     leukemic cells, negative feed anti-apoptotic mechanism. Blood.                 13: 223&#226;&#8364;&#8220;235. <br /> 60. Katoh Y, Katoh M (2008) Integrative genomic analyses GLI2: mechanism                   73. Yamaguchi M, Fujimori-Tonou N, Yoshimura Y, Kishi T, Okamoto H, et al. <br />     Hedgehog priming basal GLI2 expression, interaction map stem                      (2008) Mutation DNA primase causes extensive apoptosis retinal neurons <br />     cell signaling network P53. Int J Oncol 33: 881&#226;&#8364;&#8220;886.                                        activation DNA damage checkpoint tumor suppressor p53. <br /> 61. Park HC, Boyce J, Shin J, Appel B (2005) Oligodendrocyte specification                        Development 135: 1247&#226;&#8364;&#8220;1257. <br />     zebrafish requires notch-regulated cyclin-dependent kinase inhibitor function.               74. Fischer S, Prykhozhij S, Rau MJ, Neumann CJ (2007) Mutation zebrafish caf- <br />     J Neurosci 25: 6836&#226;&#8364;&#8220;6844.                                                                        1b results S phase arrest, defective differentiation, p53-mediated apoptosis <br /> 62. Georgia S, Soliz R, Li M, Zhang P, Bhushan (2006) p57 Hes1 coordinate                      organogenesis. Cell Cycle 6: 2962&#226;&#8364;&#8220;2969. <br />     cell cycle exit self-renewal pancreatic progenitors. Dev Biol 298: 22&#226;&#8364;&#8220;31. <br />                                                                                                  75. Lin T, Chao C, Saito S, Mazur SJ, Murphy  et al. (2005) p53 induces <br /> 63. Riccio O, van Gijn  Bezdek AC, Pellegrinet L, van Es JH, et al. (2008) Loss <br />                                                                                                      differentiation mouse embryonic stem cells suppressing Nanog expression. <br />     intestinal crypt progenitor cells owing inactivation Notch1                                                                                                      Nat Cell Biol 7: 165&#226;&#8364;&#8220;171. <br />     Notch2 accompanied derepression CDK inhibitors p27Kip1                                                                                                  76. Qin H, Yu T, Qing T, Liu Y, Zhao Y, et al. (2007) Regulation apoptosis     p57Kip2. EMBO Rep 9: 377&#226;&#8364;&#8220;383. <br />                                                                                                      differentiation p53 human embryonic stem cells. J Biol Chem 282: <br /> 64. Jia J, Lin M, Zhang L, York JP, Zhang P (2007) Notch signaling pathway <br />                                                                                                      5842&#226;&#8364;&#8220;5852. <br />     controls size ocular lens directly suppressing p57Kip2 expression. <br />     Mol Cell Biol 27: 7236&#226;&#8364;&#8220;7247.                                                                 77. Schauerte  van Eeden FJ, Fricke C, Odenthal J, Stra&#194;&#168;hle U, et al. (1998) <br /> 65. Chen D, Opavsky R, Pacal M, Tanimoto N, Wenzel P, et al. (2007) Rb-                              Sonic hedgehog required induction medial floor plate cells     mediated neuronal differentiation cell-cycle-independent regulation                   zebrafish. Development 125: 2983&#226;&#8364;&#8220;2993. <br />     E2f3a. PLoS Biol 5: e179.                                                                    78. Westerfield M (19 <br /> </body></html>